Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents
- PMID: 15631008
Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents
Abstract
The efficacy of several povidone-iodine (PVP-I) products, a number of other chemical agents, and various physical conditions were evaluated for their ability to inactivate the severe acute respiratory syndrome coronavirus (SARS-CoV). Treatment of SARS-CoV with PVP-I products for 2 min reduced the virus infectivity from 1.17 x 10(6) TCID50/ml to below the detectable level. The efficacy of 70% ethanol was equivalent to that of PVP-I products. Fixation of SARS-CoV-infected Vero E6 cells with a fixative including formalin, glutaraldehyde, methanol, and acetone for 5 min or longer eliminated all infectivity. Heating the virus at 56 degrees C for 5 min dramatically reduced the infectivity of the virus from 2.6 x 10(7) to 40 TCID50/ml, whereas heating the virus for 60 min or longer eliminated all infectivity. Irradiation with ultraviolet light at 134 microW/cm2 for 15 min reduced the infectivity from 3.8 x 10(7) to 180 TCID50/ml; however, prolonged irradiation (60 min) failed to eliminate the remaining virus, leaving 18.8 TCID50/ml. We believe that these findings will be useful for the implementation of infection control measures against SARS, and for the establishment of effective guidelines for the prevention of SARS outbreaks.
Similar articles
-
Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents.Dermatology. 2006;212 Suppl 1(Suppl 1):119-23. doi: 10.1159/000089211. Dermatology. 2006. PMID: 16490989 Free PMC article.
-
Viral Inactivation with Emphasis on SARS-CoV-2 Using Physical and Chemical Disinfectants.ScientificWorldJournal. 2021 Oct 25;2021:9342748. doi: 10.1155/2021/9342748. eCollection 2021. ScientificWorldJournal. 2021. PMID: 34712107 Free PMC article. Review.
-
Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products.Transfusion. 2006 Oct;46(10):1770-7. doi: 10.1111/j.1537-2995.2006.00976.x. Transfusion. 2006. PMID: 17002634 Free PMC article.
-
In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2.JAMA Otolaryngol Head Neck Surg. 2020 Nov 1;146(11):1054-1058. doi: 10.1001/jamaoto.2020.3053. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32940656 Free PMC article.
-
Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.Ear Nose Throat J. 2020 Nov;99(9):586-593. doi: 10.1177/0145561320932318. Epub 2020 Jun 10. Ear Nose Throat J. 2020. PMID: 32520599 Review.
Cited by
-
Management in oral and maxillofacial surgery during the COVID-19 pandemic: Our experience.Br J Oral Maxillofac Surg. 2020 Jul;58(6):687-691. doi: 10.1016/j.bjoms.2020.04.025. Epub 2020 Apr 27. Br J Oral Maxillofac Surg. 2020. PMID: 32386671 Free PMC article.
-
Povidone-iodine gargle as a prophylactic intervention to interrupt the transmission of SARS-CoV-2.Oral Dis. 2021 Apr;27 Suppl 3(Suppl 3):752-753. doi: 10.1111/odi.13378. Epub 2020 May 26. Oral Dis. 2021. PMID: 32352615 Free PMC article. No abstract available.
-
Proposal for the return to routine endoscopy during the COVID-19 pandemic.Gastrointest Endosc. 2020 Sep;92(3):735-742. doi: 10.1016/j.gie.2020.04.050. Epub 2020 Apr 28. Gastrointest Endosc. 2020. PMID: 32360301 Free PMC article.
-
Environmental and decontamination issues for human coronaviruses and their potential surrogates.J Med Virol. 2020 Nov;92(11):2498-2510. doi: 10.1002/jmv.26170. Epub 2020 Jul 2. J Med Virol. 2020. PMID: 32530505 Free PMC article. Review.
-
Control of SARS-CoV-2 transmission in orthodontic practice.Am J Orthod Dentofacial Orthop. 2020 Sep;158(3):321-329. doi: 10.1016/j.ajodo.2020.05.006. Epub 2020 Jun 5. Am J Orthod Dentofacial Orthop. 2020. PMID: 32682660 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous